Friedrich & ClementBETA

How to bid in this country: portals, deadlines, thresholds →

Open House Original Discount Agreements 2025-08 - Roxadustat

Open House Originale Rabattverträge 2025-08 - Roxadustat — original title

DEGermany · Hamburg
Open-house procedure. Any company meeting the conditions can join the contract — there is no competition for an award. The date shown is the end of the joining phase or of the contract term.

Your path to submission

  1. Deadline: 31 October at 23:58 — ends today. The buyer has changed the deadline — previously 31 March 2027.
  2. You submit on Vergabemarktplatz (cosinex) — not here and not by e-mail. ↗ Free bidder account on the cosinex platform required (created instantly); offers go through the bidding tool, usually plain text form suffices — no qualified signature. Sort out account and signature first — not on submission day.
  3. Offer and evidence in: German.
  4. Collect your evidence — use the eligibility analysis on this page: it lists the requirements and, for known certificates, how to get them.
Compiled automatically from notice and documents — no guarantee; the procedure's wording is binding.

What the buyer is looking for

The aim of the TK is to conclude discount agreements with all suitable pharmaceutical entrepreneurs pursuant to Paragraph 130c(1) of the SGB V on the active substance roxadustate. The contract is concluded within the framework of the TK's open-house original procedure: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee any exclusivity to individual contractual partners. The duration of the contract is a maximum of 24 months starting on 01.04.2025. The contract ends no later than 31.03.2027, regardless of the date of conclusion of the contract. If the patent expires/market exclusivity expires before the above-mentioned end date, the contract ends automatically at the end of the month of the patent expiry/market exclusivity. Joining this open-house original procedure is possible at any time within the contract period. Due to the…

Show full description

… existence of industrial property rights with regard to the active substance or the combination of active substances at issue in the proceedings, the participation and contractual documents are only made available to pharmaceutical entrepreneurs who offer/place on the market medicinal products for the active substance or combination of active substances at issue in the proceedings or who make it credible to TK that they intend to offer/place such medicinal products on the market within the term of the contract.

Machine translation (EU eTranslation) — official wording via the PDF link.

Contract

TypeSupplies
Estimated valuevalue not published
Published21 Feb 2025
ProcedureVgV

Type of service

33 · Medical equipment & pharma
CPV 33600000

Clement What the numbers say about this buyer

  • In this sector the buyer awards roughly every 2 months (710 awards, most recently October 2026) — the next award is due around December 2026 by that rhythm. The last award went to Siehe im Feld "Allgemeine Informationen".n = 710
  • The median procedure drew 5 bids (1,364 procedures with a bid count); 27% ended with a single bidder. Sector: median 2 bids.n = 1,364
  • 56% of this buyer's awards went to companies that had already won here before (1,519 awards since 2013, spread over 581 companies). 44% went to new names.n = 1,519 awards since 2013
  • 61% of the bids received came from small and medium-sized enterprises (21 procedures with a bid mix). Sector: 38%.n = 21
  • From notice to award takes a median 150 days here (238 procedures). Sector: 90 days.n = 238

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 31/10/2026.

Clement
References and certificates from your home country count fully across the EU — that is what European procurement law is for.

What you must prove — eligibility criteria

From the notice of the same procedure on TED — Tenders Electronic Daily.

›
Share of subcontractors
Gemäß § 130c Abs. 1 SGB V können Rabattverträge nur mit pharmazeutischen Unternehmern i. S. d. § 4 Abs. 18 AMG abgeschlossen werden, wobei sich die Eigenschaft der Vertragspartner als pharmazeutische Unternehmer auf die jeweils angebotenen Arzneimittel bezieht… read in fullcollapse
Gemäß § 130c Abs. 1 SGB V können Rabattverträge nur mit pharmazeutischen Unternehmern i. S. d. § 4 Abs. 18 AMG abgeschlossen werden, wobei sich die Eigenschaft der Vertragspartner als pharmazeutische Unternehmer auf die jeweils angebotenen Arzneimittel bezieht. Es wird darauf hingewiesen, dass Arzneimittel im Geltungsbereich des AMG nur durch einen pharmazeutischen Unternehmer in den Verkehr gebracht werden dürfen, der seinen Sitz im Geltungsbereich des AMG, in einem anderen Mitgliedstaat der Europäischen Union oder in einem anderen Vertragsstaat des Abkommens über den Europäischen Wirtschaftsraum hat (§ 9 Abs. 2 Satz 1 AMG). Örtliche Vertreter eines pharmazeutischen Unternehmers können sich nur dann beteiligen, wenn sie selbst pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMG hinsichtlich der jeweils angebotenen Arzneimittel sind. Folgende Eignungsvoraussetzungen müssen für einen Vertragsschluss erfüllt und im Rahmen der Eigenerklärung zur Zulassung und zum Unternehmen (Anlage 4 zum Vertrag) durch Unterzeichnung in Textform nach § 126b GBG bestätigt werden: I. Eigenerklärung zur Zulassung Wir versichern, dass - wir pharmazeutischer Unternehmer im Sinne von § 4 Absatz 18 Arzneimittelgesetz (AMG) sind, wobei sich diese Eigenschaft auf das/die vertragsgegenständliche/n Rabattarzneimittel bezieht, - wir unseren Sitz im Geltungsbereich des AMG, einem anderen Mitgliedstaat der Europäischen Union oder in einem anderen Vertragsstaat des Abkommens über den Europäischen Wirtschaftsraum haben (§ 9 Absatz 2 Satz 1 AMG), - wir über eine gültige Zulassung für das/die vertragsgegenständliche/n Rabattarzneimittel gemäß § 21 Absatz 1 Satz 1 AMG verfügen und/oder aus sonstigem Grund zum Inverkehrbringen des/der vertragsgegenständliche/n Rabattarzneimittel/s in eigenem Namen berechtigt sind (§ 4 Absatz 18 Satz 2 AMG) sowie - zum Zeitpunkt der Absendung der Vertragsunterlagen (an die TK) keine Gründe vorliegen, die zur Unwirksamkeit der Zulassung führen oder zu Rücknahme, Widerruf bzw. Ruhensanordnung im Sinne von § 30 AMG der Zulassung berechtigen. II. Eigenerklärung zur Zuverlässigkeit Bei uns führt keine rechtskräftige Verurteilung innerhalb der letzten fünf Jahre zu einem Ausschlussgrund analog § 123 GWB. Darüber hinaus führt auch kein Ereignis innerhalb der letzten drei Jahre zu einem Ausschlussgrund analog § 124 GWB. Falls Sie diese Erklärung nicht oder nur eingeschränkt abgeben können, reichen Sie bitte eine ergänzende Erläuterung ein und erklären, warum Sie dennoch aus Ihrer Sicht nicht von der Teilnahme an dem Open-House-Verfahren auszuschließen sind.
Requirement texts are quoted in the notice's original language — only the official wording is binding.

Tender documents — direct download

⤓
Annex
Specifications and annexes at the buyer — usually viewable without registration

Who has won at this buyer so far

Across all contract types of this buyer — not just this sector. A city buys software and fire engines through the same purchasing office.

CompanyAwardsPeriod
Computacenter AG & Co. oHG762006–2026
Siehe im Feld "Allgemeine Informationen"592023–2026
Hexal AG · Holzkirchen432011–2026
Aliud Pharma GmbH · Laichingen392011–2026
Aristo Pharma GmbH · Berlin332012–2026
From the recorded awards · regular winners know this buyer's requirements — that is your competition.

How often this buyer tenders this kind of work

53
2019
29
2020
22
2021
29
2022
54
2023
215
2024
1
2025
362
2025
206
2026
971 procedures in this category since 2019. Public procurement repeats itself — those who know the rhythm prepare instead of reacting.

Contracting authority contact

·
Deadline — Saturday 31 October at 23:58

Tactics

When this buyer has awarded in this sector, usually 16 or more bids came in. Many compete here — price and references decide. (Based on 1,319 completed awards — not a statement about this procedure.)

This procedure allows 618 days between publication and deadline — typical in this country is 32 (median of 20,071 procedures). Much more generous than usual — time for a thorough bid rather than a quick one.

Foreign bidders

In Germany · Medical equipment & pharma, 270 contracts went to foreign companies over the last 3 years (of 22,355 recorded awards) — mostly from Austria, Netherlands, France.

Submission language: German.

Measured from linked award data; foreign winners bidding through a local subsidiary count as domestic — the true share is higher.

How to bid

Guide: how to apply on cosinex Vergabemarktplatz / DTVP → Registration, signature, fees — from the operator's bidder manual.

Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
This procedure is published on 3 portals
Bids are submitted on Vergabemarktplatz (cosinex) — TED carries the same notice, usually with the more detailed specification. Read both.
Put together the evidence — in German
The criterion on the left, plus your price.
Submit via Vergabemarktplatz (cosinex) before the deadline
Electronic submission — allow time for the portal registration the first time.
To the procurement portal (submission) →Official notice on TED →
We pull data from millions of notices. If the link here does not work, report it — we will find the right one.

Don't miss the next one

Friedrich finds tenders like this for you — every morning at 7:30, each one checked by Claude (Anthropic) for fit, and he learns from your feedback what your company really does.

Register now